Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Background. Impaired cognitive functions in schizophrenia are the major deciding factors in response to treatment. Conventional antipsychotics have minimal impact on cognitive dysfunctions and are associated with adverse effects. Atypical antipsychotics have shown promise in treatment of cognitive a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Ganesh R., Phadnis, P., Paliwal, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658793/
https://www.ncbi.nlm.nih.gov/pubmed/23738210
http://dx.doi.org/10.5402/2012/703751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658793/
https://www.ncbi.nlm.nih.gov/pubmed/23738210
http://dx.doi.org/10.5402/2012/703751

Ejemplares similares